1. Geldanamycin prevents hemorrhage-induced ATP loss by overexpressing inducible HSP70 and activating pyruvate dehydrogenase
- Author
-
Kiang, Juliann G., Bowman, Phillip D., Lu, Xinyue, Li, Yansong, Ding, Xuan Z., Zhao, Baiteng, Juang, Yuang-Taung, Atkins, James L., and Tsokos, George C.
- Subjects
Heat shock proteins -- Research ,Intestines -- Research ,Adenosine triphosphatase -- Research ,Biological sciences - Abstract
Hemorrhage in mice results in decreased ATP levels in the jejunum, lung, kidney, heart, and brain but not in liver tissue lysates, albeit at variable levels and time kinetics. The decreased protein expression and activity of pyruvate dehydrogenase (PDH) accounted for the hemorrhage-induced ATP loss. Treatment with geldanamycin (GA: 1 [micro]g/g body wt), a known inducer of heat shock protein (HSP)70, inhibited the hemorrhage-induced ATP loss in the jejunum, lung, heart, kidney, and brain. GA was found to increase PDH protein, preserve PDH enzymatic activity, and inhibit mucosal injury in jejunum tissues. GA-induced HSP70i was found to form complexes with PDH protein. HSP70 gene transfer into intestinal epithelial cells promoted PDH and ATP levels, whereas HSP70 short interfering RNA limited them. We conclude that agents able to increase the expression of HSP70 and PDH may be of value in reducing pathology resulting from hemorrhage-associated ATP loss. heat shock protein 70; intestine
- Published
- 2006